E&G Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
E&G Advisors's IBB Position: Q3 2026 in Review
E&G Advisors opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 1,136 shares worth $239K. The stake represents 0.05% of the portfolio and ranks #225 among its holdings. This is a return to the name: E&G Advisors previously reported a position in IBB as recently as Q4 2015.
E&G Advisors first reported a position in IBB in Q3 2014 and has held it in 7 quarters since. The position peaked at $678K in Q1 2015. 1,019 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- E&G Advisors held 1,136 shares of iShares Biotechnology ETF worth $239K as of Q3 2026.
- iShares Biotechnology ETF was a new E&G Advisors position in Q3 2026.
- iShares Biotechnology ETF made up 0.05% of E&G Advisors's portfolio in Q3 2026, its #225 holding.
- E&G Advisors first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 7 quarters since.
- E&G Advisors's iShares Biotechnology ETF position peaked at $678K in Q1 2015.
- 1,019 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on E&G Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.